HIV viral suppression in the era of dolutegravir use: Findings from a national survey in Tanzania

• Published in: PloS one Vol. 19; no. 8; p. e0307003
• Main Authors: Kamori, Doreen, Barabona, Godfrey, Maokola, Werner, Rugemalila, Joan, Mahiti, Macdonald, Mizinduko, Mucho, Sabasaba, Amon, Ruhago, George, Mlunde, Linda, Masoud, Salim S., Amani, Davis, Mboya, Erick, Mugusi, Sabina, Rwebembera, Anath, Mgomella, George, Asiimwe, Sarah, Mutayoba, Beatrice, Njau, Prosper, Ueno, Takamasa, Pembe, Andrea, Sunguya, Bruno
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 14.08.2024; Public Library of Science (PLoS)
• Subjects: Acquired immune deficiency syndrome; Adolescent; Adult; Adults; Age; AIDS; Anti-HIV Agents - therapeutic use; Antiretroviral agents; Antiretroviral drugs; Antiretroviral therapy; Antiviral agents; Biological products industry; Biology and Life Sciences; Blood; Care and treatment; Child; Child, Preschool; Children; Cross-Sectional Studies; Data collection; Drug resistance; Ethylenediaminetetraacetic acid; Female; Females; Health facilities; Heterocyclic Compounds, 3-Ring - therapeutic use; Highly active antiretroviral therapy; HIV; HIV (Viruses); HIV Infections - drug therapy; HIV Infections - epidemiology; HIV Infections - virology; HIV Integrase Inhibitors - therapeutic use; HIV-1 - drug effects; HIV-1 - genetics; Human immunodeficiency virus; Humans; International economic relations; Laboratories; Logistics; Male; Mean; Medicine and Health Sciences; Middle Aged; Oxazines - therapeutic use; People and Places; Piperazines - therapeutic use; Pyridones - therapeutic use; Real time; Regression analysis; Sample size; Sexually transmitted diseases; Software; STD; Surveys; Tanzania - epidemiology; Viral Load - drug effects; Young Adult; Tanzania

Tanzania has made significant progress in improving access to HIV care and treatment. However, virologic suppression among people living with HIV (PLHIV) has not been fully realized. In March 2019, Tanzania introduced a World Health Organization (WHO)-recommended dolutegravir-based regimen as the de...